(NP (NP (NN Purpose)) (: :) (S (VP (TO To) (VP (VB evaluate) (NP (NP (NP (NNP Pegasus)) (HYPH -) (NP (NN OCT))) (, ,) (NP (NP (DT a) (JJ clinical) (NN decision) (NN support) (NN software)) (PP (IN for) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (NNS features)) (PP (IN of) (NP (JJ retinal) (NN disease))))))))) (PP (IN from) (NP (NN macula) (NN OCT) (NNS scans))) (, ,) (PP (IN across) (NP (NP (JJ heterogenous) (NNS populations)) (VP (VBG involving) (S (VP (VBG varying) (NP (NP (JJ patient) (NNS demographics)) (, ,) (NP (NN device) (NNS manufacturers)) (, ,) (NP (NN acquisition) (NNS sites)) (CC and) (NP (NNS operators))))))))))) (. .))
(FRAG (NP (NNS Methods)) (: :) (S (NP (NP (NP (CD 5,588) (ADJP (JJ normal) (CC and) (JJ anomalous)) (JJ macular) (NN OCT) (NNS volumes)) (-LRB- -LRB-) (NP (CD 162,721) (NN B) (HYPH -) (NNS scans)) (-RRB- -RRB-)) (, ,) (VP (VBN acquired) (PP (IN at) (NP (NP (JJ independent) (NNS centres)) (PP (IN in) (NP (CD five) (NNS countries)))))) (, ,)) (VP (VBD were) (VP (VBN processed) (S (VP (VBG using) (NP (DT the) (NN software))))))) (. .))
(S (NP (NNS Results)) (VP (VBD were) (VP (VBN evaluated) (PP (IN against) (NP (NP (NN ground) (NN truth)) (VP (VBN provided) (PP (IN by) (NP (DT the) (NN dataset) (NNS owners)))))))) (. .))
(NP (NP (NNS Results)) (: :) (NP (NP (NNP Pegasus)) (: -) (NP (NP (NN OCT)) (VP (VBN performed) (PP (IN with) (NP (NP (NNS AUROCs)) (PP (IN of) (NP (NP (QP (ADVP (IN at) (RBS least)) (CD 98)) (NN %)) (PP (IN for) (NP (DT all) (NNS datasets))))))) (PP (IN in) (NP (NP (DT the) (NN detection)) (PP (IN of) (NP (JJ general) (JJ macular) (NNS anomalies)))))))) (. .))
(S (PP (IN For) (NP (NP (NNS scans)) (PP (IN of) (NP (JJ sufficient) (NN quality))))) (, ,) (NP (NP (DT the) (NNS AUROCs)) (PP (IN for) (NP (JJ general) (NML (NNP AMD) (CC and) (NNP DME)) (NN detection)))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB be) (NP (NP (QP (ADVP (IN at) (RBS least)) (CD 99)) (NN %)) (CC and) (NP (CD 98) (NN %))) (, ,) (ADVP (RB respectively))))))) (. .))
(NP (NP (NNS Conclusions)) (: :) (NP (NP (DT The) (NN ability)) (PP (IN of) (NP (DT a) (JJ clinical) (NN decision) (NN support) (NN system))) (S (VP (TO to) (VP (VB cater) (SBAR (IN for) (S (NP (JJ different) (NNS populations)) (VP (VBZ is) (ADJP (JJ key) (PP (IN to) (NP (PRP$ its) (NN adoption))))))))))) (. .))
(S (NP (NP (NNP Pegasus)) (HYPH -) (NP (NN OCT))) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ able) (S (VP (TO to) (VP (VB detect) (NP (NP (NNP AMD)) (, ,) (NP (NNP DME)) (CC and) (NP (JJ general) (NNS anomalies))) (PP (IN in) (NP (NP (NN OCT) (NNS volumes)) (VP (VBN acquired) (PP (IN across) (NP (JJ multiple) (JJ independent) (NNS sites))) (PP (IN with) (NP (JJ high) (NN performance))))))))))))))) (. .))
(S (NP (PRP$ Its) (NN use)) (ADVP (RB thus)) (VP (VBZ offers) (NP (JJ substantial) (NN promise)) (, ,) (PP (IN with) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB alleviate) (NP (NP (DT the) (NN burden)) (PP (IN of) (NP (NP (VBG growing) (NN demand)) (PP (IN in) (NP (NP (NML (NN eye) (NN care)) (NNS services)) (VP (VBN caused) (PP (IN by) (NP (JJ retinal) (NN disease))))))))))))))) (. .))
